Population pharmacokinetics and optimization of the dosing regimen of digoxin in adult patients [0.03%]
成人患者的地高辛群体药代动力学及剂量调整优化研究
Toshiaki Komatsu,Mami Morita,Futaba Miyaji et al.
Toshiaki Komatsu et al.
Background: This study aimed to evaluate the population pharmacokinetics of digoxin in Japanese patients and establish a dosage regimen based on the pharmacokinetic data. ...
Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease [0.03%]
克拉霉素联合左氧氟沙星治疗肺分枝杆菌鸟胞内复合菌属感染回顾性分析
Hitoshi Shimomura,Airi Ono,Keiko Imanaka et al.
Hitoshi Shimomura et al.
Background: Fluoroquinolones are often used for the treatment of refractory Mycobacterium avium complex (MAC) disease when the clinical efficacy of the recommended regimen, which includes clarithromycin (CAM), rifampicin ...
Effects of an evidence-based medicine workshop on Japanese pharmacy students' awareness regarding the importance of reading current clinical literature [0.03%]
基于证据的医学研讨会对日本药学专业学生阅读最新临床文献重要性认知的影响
Naoto Nakagawa,Yuriko Murai,Makiko Yoshida et al.
Naoto Nakagawa et al.
Background: Drug literature evaluation has been taught at pharmacy schools in the United States, allowing pharmacy students to learn how to read clinical literature critically. In advanced pharmacy practice experiences, p...
A retrospective study to identify risk factors for somnolence and dizziness in patients treated with pregabalin [0.03%]
一项回顾性研究：识别普瑞巴林治疗患者的嗜睡和头晕危险因素
Hiroshi Kato,Masayuki Miyazaki,Mio Takeuchi et al.
Hiroshi Kato et al.
Background: Pregabalin is a therapeutic drug for neuropathic pain that is associated with somnolence and dizziness. These adverse events are often experienced shortly after initiating pregabalin, and may lead to treatment...
Active topical therapy by "Furuta method" for effective pressure ulcer treatment: a retrospective study [0.03%]
一种有效的治疗压疮的外用疗法——“古田方法”：回顾性研究
Katsunori Furuta,Fumihiro Mizokami,Hitoshi Sasaki et al.
Katsunori Furuta et al.
Background: We newly proposed that "Furuta method," a pharmacist intervention guidelines, is a topical ointment therapy that considers the physical properties and moist environment of wounds for pressure ulcer (PU) treatm...
Takae Hanada,Yoichiro Takami,Kei Moriyama et al.
Takae Hanada et al.
Background: Unintended exposure to antitumor agents from an oral medicine may place healthcare workers and patients taking medicine at risk. In this study, the exposure to blister pack by CP (cyclophosphamide) and appropr...
Differences in recognition of similar medication names between pharmacists and nurses: a retrospective study [0.03%]
药师和护士对类似药品名称识别差异的回顾性研究
Toshikazu Tsuji,Toshihiro Irisa,Shinji Tagawa et al.
Toshikazu Tsuji et al.
Background: Differences in error rates between pharmacists and nurses in terms of drug confirmation have not been studied. The purpose of this study was to analyze differences in error rates between pharmacists and nurses...
Evaluation of pharmacy practice program in the 6-year pharmaceutical education curriculum in Japan: hospital pharmacy practice program [0.03%]
日本六年度药学教育课程的药房实习项目评估：医院药房实习项目
Miho Utsumi,Sachi Hirano,Yuki Fujii et al.
Miho Utsumi et al.
Background: The objective of this study was to clarify the state of national pharmacy practice program in the 6-year course of pharmaceutical education from the students' point of view. We will suggest the points for impr...
The influence of dietary peptide inhibitors of angiotensin-converting enzyme on the hypotensive effects of enalapril [0.03%]
饮食性血管紧张素转换酶抑制肽对依那普利降压效应的影响
Machiko Watanabe,Junichi Kurihara,Shigeto Suzuki et al.
Machiko Watanabe et al.
Background: Enalapril is an antihypertensive medicine that inhibits angiotensin I-converting enzyme (ACE). The present study investigated interactions between enalapril and a fermented milk product (FMP) containing the AC...
Pharmacoepidemiology in Japan: medical databases and research achievements [0.03%]
日本的药物流行病学：医学数据库和研究成果
Shiro Tanaka,Kahori Seto,Koji Kawakami
Shiro Tanaka
Pharmacoepidemiology involves development of new models to predict safety in the development stages of pharmaceutical products, development of various guidelines and policy related to clinical trials, pharmacovigilance, establishment and im...